1. News & Events
  2. Newsroom
  3. Eli Casdin co-leads $250M infusion into microfluidics player that landed NIH funding for covid-19 testing

Eli Casdin co-leads $250M infusion into microfluidics player that landed NIH funding for covid-19 testing

Share:

EmailFacebookLinkedInXWhatsAppShare
Grantee News
January 24, 2022

Fluidigm, "the South San Francisco-based company, which landed NIH money in a Shark Tank-style program for Covid-19 testing, announced that it will take on an investment worth $250 million from Casdin Capital and Viking Global investors, ".  The company "will also rebrand, and call itself Standard BioTools.  Source: Endpoints News.
 

Explore More

Heath Topics

Research Topics

Scientific Program Areas

Inside NIBIB